Jakarta - Delayed Quote IDR

PT Jayamas Medica Industri Tbk (OMED.JK)

198.00 -1.00 (-0.50%)
At close: April 26 at 4:00 PM GMT+7
Key Events
Loading Chart for OMED.JK
DELL
  • Previous Close 199.00
  • Open 199.00
  • Bid 198.00 x --
  • Ask 198.00 x --
  • Day's Range 198.00 - 199.00
  • 52 Week Range 149.00 - 242.00
  • Volume 1,777,500
  • Avg. Volume 774,507
  • Market Cap (intraday) 5.358T
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) 20.67
  • EPS (TTM) 9.58
  • Earnings Date --
  • Forward Dividend & Yield 6.34 (3.20%)
  • Ex-Dividend Date Jun 7, 2023
  • 1y Target Est --

PT Jayamas Medica Industri Tbk manufactures and sells medical devices and supplies under the OneMed brand in Indonesia, Asia, the United States of America, South America, and Africa. The company operates through three segments: Manufacturing, Distribution, and Retail. It offers medical disposables and consumables comprising syringes, gauze, plaster bandage, masks, medical gloves, urine bag, foley cathether, alcoholic tissue, etc.; antiseptic and disinfectant liquids, povidone iodine, medical alcohol, Hdsol or blood cleansing liquid, etc.; and diagnostics and equipment, such as patient monitor, vital signs monitor, ECG reader, syringe pump, infusion pump, tensimeter, oxymeter, fingertip pulse etc. The company also provides walking aids and rehabilitation care products, including wheelchairs, crutches, walkers, arm slings etc.; biotechnology and laboratory products, such as pregnancy test, PCR test, blood collection tube, PCT tube, chemical reagents, etc; and hospital furniture products comprising patient bed, bed side cabinet, pediatric patient bed, and operation lamp, as well as other consumer medical products. It distributes and retails medical supplies and equipment through Medicom stores and online platforms. PT Jayamas Medica Industri Tbk was founded in 2000 and is headquartered in Sidoarjo, Indonesia. PT Jayamas Medica Industri Tbk operates as a subsidiary of Pt. Intisumber Hasilsempurna.

www.jmi.co.id

1,111

Full Time Employees

December 31

Fiscal Year Ends

Related News

Performance Overview: OMED.JK

Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

OMED.JK
7.48%
IDX COMPOSITE
3.25%

1-Year Return

OMED.JK
0.65%
IDX COMPOSITE
3.14%

3-Year Return

OMED.JK
--
IDX COMPOSITE
0.20%

5-Year Return

OMED.JK
--
IDX COMPOSITE
0.20%

Compare To: OMED.JK

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: OMED.JK

Valuation Measures

Annual
As of 4/26/2024
  • Market Cap

    5.36T

  • Enterprise Value

    4.36T

  • Trailing P/E

    20.65

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    3.08

  • Price/Book (mrq)

    2.42

  • Enterprise Value/Revenue

    2.51

  • Enterprise Value/EBITDA

    11.75

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    14.93%

  • Return on Assets (ttm)

    7.39%

  • Return on Equity (ttm)

    12.10%

  • Revenue (ttm)

    1.74T

  • Net Income Avi to Common (ttm)

    259.36B

  • Diluted EPS (ttm)

    9.58

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    1.18T

  • Total Debt/Equity (mrq)

    8.43%

  • Levered Free Cash Flow (ttm)

    -91.62B

Company Insights: OMED.JK

People Also Watch